Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH/PI3K/Akt signaling pathwayBingying Zhu, Hui Cong, Yafang Pan et al.|International Journal of Oncology|2018Cited by 19
Multiple primary malignant neoplasms: A case report and literature reviewLinwei Zhang, Jing Wang, Lingxin Feng et al.|Oncology Letters|2019Cited by 18